Douglass Winthrop Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $485K | Buy |
1,817
+44
| +2% | +$11.9K | 0.01% | 210 |
|
|
2025
Q4 | $445K | Buy |
1,773
+356
| +25% | +$94.5K | 0.01% | 225 |
|
|
2025
Q3 | $407K | Sell |
1,417
-273
| -16% | -$73.1K | 0.01% | 226 |
|
|
2025
Q2 | $444K | Sell |
1,690
-150
| -8% | -$36.5K | 0.01% | 195 |
|
|
2025
Q1 | $428K | Buy |
1,840
+25
| +1% | +$6.07K | 0.01% | 204 |
|
|
2024
Q4 | $416K | Buy |
1,815
+25
| +1% | +$5.74K | 0.01% | 219 |
|
|
2024
Q3 | $400K | Sell |
1,790
-25
| -1% | -$5.5K | 0.01% | 218 |
|
|
2024
Q2 | $369K | Buy |
1,815
+25
| +1% | +$5.08K | 0.01% | 218 |
|
|
2024
Q1 | $391K | Sell |
1,790
-225
| -11% | -$49.6K | 0.01% | 209 |
|
|
2023
Q4 | $458K | Sell |
2,015
-225
| -10% | -$47.3K | 0.01% | 183 |
|
|
2023
Q3 | $450K | Sell |
2,240
-1,246
| -36% | -$263K | 0.01% | 171 |
|
|
2023
Q2 | $723K | Sell |
3,486
-233
| -6% | -$45.2K | 0.02% | 141 |
|
|
2023
Q1 | $733K | Buy |
3,719
+122
| +3% | +$25.1K | 0.02% | 138 |
|
|
2022
Q4 | $728K | Hold |
3,597
| – | – | 0.02% | 139 |
|
|
2022
Q3 | $633K | Sell |
3,597
-29
| -0.8% | -$5.94K | 0.02% | 140 |
|
|
2022
Q2 | $730K | Hold |
3,626
| – | – | 0.02% | 139 |
|
|
2022
Q1 | $821K | Sell |
3,626
-29
| -0.8% | -$6.82K | 0.02% | 144 |
|
|
2021
Q4 | $987K | Sell |
3,655
-233
| -6% | -$57.7K | 0.02% | 134 |
|
|
2021
Q3 | $940K | Hold |
3,888
| – | – | 0.02% | 139 |
|
|
2021
Q2 | $921K | Buy |
3,888
+233
| +6% | +$53.1K | 0.02% | 146 |
|
|
2021
Q1 | $801K | Hold |
3,655
| – | – | 0.02% | 154 |
|
|
2020
Q4 | $639K | Sell |
3,655
-7
| -0.2% | -$1.21K | 0.02% | 164 |
|
|
2020
Q3 | $592K | Buy |
3,662
+1,520
| +71% | +$241K | 0.02% | 158 |
|
|
2020
Q2 | $306K | Buy |
+2,142
| New | +$296K | 0.01% | 211 |
|
|
2019
Q3 | – | Sell |
-1,705
| Closed | -$253K | – | 262 |
|
|
2019
Q2 | $253K | Hold |
1,705
| – | – | 0.01% | 234 |
|
|
2019
Q1 | $224K | Sell |
1,705
-3,632
| -68% | -$447K | 0.01% | 225 |
|
|
2018
Q4 | $579K | Hold |
5,337
| – | – | 0.03% | 150 |
|
|
2018
Q3 | $796K | Sell |
5,337
-3,492
| -40% | -$531K | 0.04% | 132 |
|
|
2018
Q2 | $1.36M | Buy |
8,829
+3,492
| +65% | +$527K | 0.06% | 127 |
|
|
2018
Q1 | $742K | Buy |
5,337
+1,135
| +27% | +$167K | 0.04% | 165 |
|
|
2017
Q4 | $576K | Hold |
4,202
| – | – | 0.03% | 160 |
|
|
2017
Q3 | $545K | Buy |
4,202
+495
| +13% | +$66K | 0.03% | 163 |
|
|
2017
Q2 | $491K | Hold |
3,707
| – | – | 0.03% | 165 |
|
|
2017
Q1 | $457K | Hold |
3,707
| – | – | 0.03% | 170 |
|
|
2016
Q4 | $409K | Hold |
3,707
| – | – | 0.03% | 171 |
|
|
2016
Q3 | $438K | Buy |
3,707
+75
| +2% | +$8.84K | 0.03% | 166 |
|
|
2016
Q2 | $406K | Hold |
3,632
| – | – | 0.03% | 169 |
|
|
2016
Q1 | $365K | Hold |
3,632
| – | – | 0.03% | 172 |
|
|
2015
Q4 | $386K | Buy |
3,632
+722
| +25% | +$74.5K | 0.03% | 176 |
|
|
2015
Q3 | $271K | Hold |
2,910
| – | – | 0.02% | 202 |
|
|
2015
Q2 | $315K | Hold |
2,910
| – | – | 0.02% | 198 |
|
|
2015
Q1 | $315K | Sell |
2,910
-29
| -1% | -$2.98K | 0.02% | 198 |
|
|
2014
Q4 | $272K | Sell |
2,939
-227
| -7% | -$20.1K | 0.02% | 179 |
|
|
2014
Q3 | $277K | Sell |
3,166
-183,464
| -98% | -$16.6M | 0.03% | 172 |
|
|
2014
Q2 | $16.4M | Buy |
186,630
+826
| +0.4% | +$71.5K | 1.51% | 28 |
|
|
2014
Q1 | $15.7M | Buy |
185,804
+12,967
| +8% | +$1.03M | 1.55% | 27 |
|
|
2013
Q4 | $13.6M | Buy |
172,837
+7,584
| +5% | +$647K | 1.41% | 29 |
|
|
2013
Q3 | $14.1M | Buy |
165,253
+4,656
| +3% | +$392K | 1.63% | 26 |
|
|
2013
Q2 | $13.8M | Buy |
+160,597
| New | +$13.3M | 1.67% | 24 |
|
Other funds holding LH
VCM
VPM
Douglass Winthrop Advisors's LH Position: Q1 2026 in Review
Douglass Winthrop Advisors increased its Labcorp (LH) stake by 2.5% in Q1 2026, buying an estimated $11.9K and bringing the position to 1,817 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #210.
Douglass Winthrop Advisors first reported a position in LH in Q2 2013 and has held it in 49 quarters since. The position peaked at $16.4M in Q2 2014. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Douglass Winthrop Advisors held 1,817 shares of Labcorp worth $485K as of Q1 2026.
- Douglass Winthrop Advisors bought 44 Labcorp shares in Q1 2026, an estimated $11.9K.
- Labcorp made up 0.01% of Douglass Winthrop Advisors's portfolio in Q1 2026, its #210 holding.
- Douglass Winthrop Advisors first reported a position in Labcorp in Q2 2013 and has held it in 49 quarters since.
- Douglass Winthrop Advisors's Labcorp position peaked at $16.4M in Q2 2014.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Douglass Winthrop Advisors's 13F filing for Q1 2026, filed 14 May 2026.